Schedule 13G ownership disclosure
Checkpoint Therapeutics, Inc.
Security class unavailable · CUSIP: 162828107
Event date: 2020-09-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,571,429
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-108604
- Form type
- SC 13G
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Sep 25, 2020
- Reporting period
- Sep 17, 2020
- Description
- Schedule 13G beneficial ownership